| |
| |
|
| Insider
Information: |
Cassidy Bernard J |
| Relationship: |
Officer |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
134,031 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
134,031 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tessera Technologies Inc |
TSRA |
EVP & GC, TIPC President |
2013-03-06 |
41,250 |
2008-11-17 |
0 |
Premium* |
|
|
Juno Therapeutics, Inc. |
JUNO |
General Counsel & Secr... |
2018-03-05 |
0 |
2018-03-05 |
0 |
Premium* |
|
|
Sana Biotechnology, Inc. |
SANA |
Officer |
2022-09-12 |
92,781 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SANA |
Sana Biotechnology, Inc. |
EVP & General CounselOfficer |
• – – |
2022-09-12 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
92,781 |
|
- |
|
| SANA |
Sana Biotechnology, Inc. |
EVP & General Counsel |
• – – |
2022-09-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
82,031 |
|
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2018-03-05 |
4 |
D |
$87.00 |
$2,337,603 |
I/I |
(26,869) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2018-03-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(79,825) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2018-03-05 |
4 |
D |
$87.00 |
$483,546 |
D/D |
(5,558) |
79,825 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2018-02-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
26,634 |
85,262 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2018-02-07 |
4 |
D |
$85.49 |
$130,629 |
D/D |
(1,528) |
111,896 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25,639 |
113,424 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2017-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
35,893 |
86,917 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2017-09-14 |
4 |
AS |
$44.67 |
$1,257,766 |
D/D |
(28,000) |
51,024 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
24,390 |
79,024 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2016-05-19 |
4 |
AS |
$38.77 |
$121,603 |
D/D |
(3,116) |
54,634 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2016-04-19 |
4 |
AS |
$43.00 |
$137,999 |
D/D |
(3,200) |
57,283 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel & Secretary |
• – – |
2016-03-18 |
4 |
AS |
$37.96 |
$122,171 |
D/D |
(3,200) |
60,483 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2016-02-19 |
4 |
AS |
$34.45 |
$110,389 |
D/D |
(3,200) |
63,683 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2016-01-19 |
4 |
AS |
$33.37 |
$107,373 |
D/D |
(3,200) |
66,883 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2015-12-18 |
4 |
AS |
$45.02 |
$145,235 |
D/D |
(3,200) |
70,083 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2015-11-19 |
4 |
AS |
$52.91 |
$169,500 |
D/D |
(3,200) |
71,200 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2015-10-19 |
4 |
AS |
$49.42 |
$159,518 |
D/D |
(3,200) |
74,400 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2015-09-18 |
4 |
AS |
$42.30 |
$503,629 |
D/D |
(11,850) |
77,600 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2015-08-19 |
4 |
AS |
$40.06 |
$475,733 |
D/D |
(11,850) |
89,450 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2015-07-17 |
4 |
AS |
$50.45 |
$598,977 |
D/D |
(11,850) |
101,300 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2015-06-24 |
4 |
AS |
$51.22 |
$608,336 |
D/D |
(11,850) |
113,150 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2014-12-23 |
4 |
A |
$0.00 |
$0 |
I/I |
26,689 |
26,689 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
General Counsel and Secretary |
• – – |
2014-12-23 |
4/A |
A |
$0.00 |
$0 |
I/I |
26,869 |
26,869 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
